Oropharyngeal Neoplasms: all 378 studies
Page 3 of 4. Open to participants first (99), then studies with results posted, then the rest; newest registration first within each.
- Study of Lymphatic Drainage Mapping in Oropharyngeal CancersCompletedNCT05055206Not applicable
- Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck CancerActive, not recruitingNCT05050162Phase 2/3
- Adaptative Radiotherapy to Decrease Xerostomia in Oropharynx Carcinoma (ARTOME)CompletedNCT05025618
- Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant TherapyActive, not recruitingNCT04920344Phase 2
- A Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor / Adenosine 2b Receptor Inhibitor AB928 Therapies in Locally Advanced Head and Neck CancersWithdrawnNCT04892875Phase 1
- Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal CancerActive, not recruitingNCT04874493
- Improving Detection and Early Action for HPV-positive Oropharynx CancerCompletedNCT04871490Not applicable
- Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and NeckActive, not recruitingNCT04862650Phase 2
- Effect of Low-level Laser Therapy on Salivary Flow, pH and Quality of Life in Irradiated Oropharyngeal Cancer PatientsCompletedNCT04738227Not applicable
- Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival TrialActive, not recruitingNCT04713449Not applicable
- A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon CancersCompletedNCT04708470Phase 1/2
- Prospective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyngeal Squamous Cell Carcinoma: CTCO (Circulating Tumor Cells in the Oropharynx)CompletedNCT04696744
- Radiotherapy Dose De-escalation in HPV-Associated Cancers of the OropharynxActive, not recruitingNCT04667585Not applicable
- Clonidine HCl MBT vs. Placebo to Prevent Chemoradiotherapy-Induced Severe Oral Mucositis in Oropharyngeal Cancer.TerminatedNCT04648020Phase 2/3
- De-Escalation Protocol Of HPV Mediated Oropharyngeal Squamous Cell CarcinomaActive, not recruitingNCT04638465
- A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical CancerTerminatedNCT04630353Early Phase 1
- Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)Active, not recruitingNCT04609280Phase 2
- Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal CancerCompletedNCT04572100Phase 1
- Proteome- and Methylation Profiles in Oropharyngeal CancerCompletedNCT04567082
- Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take CisplatinActive, not recruitingNCT04533750Phase 1
- Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction ChemotherapyStatus unknownNCT04508829Phase 2
- Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown PrimariesCompletedNCT04489212Not applicable
- Prevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Oropharynx Treatment by Combined ChemoradiotherapyStatus unknownNCT04440618
- QUantitative Assessment of Swallowing After Radiation (QUASAR)Status unknownNCT04359199
- Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid TumorsTerminatedNCT04301011Phase 1
- Evaluation of the Photobiomodulation Using LED Lamp for Curative Treatment of Radio-induced Mucositis.CompletedNCT04251949Phase 2
- Postoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSASCompletedNCT04189107Phase 3
- Molecular Signatures of HPV+ ORL Cancers (OROPAP)CompletedNCT04189003
- A Phase 1/2 Study in Patients With HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Other CancersCompletedNCT04180215Phase 1/2
- Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal CancerWithdrawnNCT04140513Not applicable
- Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell CarcinomaActive, not recruitingNCT04124198Not applicable
- CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)Active, not recruitingNCT04116047Phase 3
- Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With HPV Positive, KRAS-Variant Stage III-IV Oropharyngeal Squamous Cell CarcinomaTerminatedNCT04106362Phase 2
- Ropivacaine/Dexamethasone and 10% Lignocaine Injection in GPN Block for Intractable Cancer PainStatus unknownNCT04085120Not applicable
- A Phase II Study of Neoadjuvant E7 TCR T Cell Immunotherapy for Borderline Resectable and Unresectable Stage I HPV-Associated Oropharyngeal CancerWithdrawnNCT04044950Phase 2
- De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese PopulationsStatus unknownNCT04012502Not applicable
- Therapy for High-Risk HPV 16-Positive Oropharynx Cancer PatientsWithdrawnNCT04001413Phase 2
- Cell-free Tumor DNA in Head and Neck Cancer PatientsStatus unknownNCT03942380Not applicable
- PEARL PET-based Adaptive Radiotherapy Clinical TrialStatus unknownNCT03935672Not applicable
- Functional Results of Soft Palate Free Flap ReconstructionCompletedNCT03890783
- Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry MouthActive, not recruitingNCT03874572Phase 1
- Feasibility and Tolerance of Nivolumab Neoadjuvant Immunotherapy in High Risk HPV Driven Oropharynx CancerCompletedNCT03838263Phase 2
- Testing Immunotherapy Versus Observation in Patients With HPV Throat CancerActive, not recruitingNCT03811015Phase 3
- EValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smokers/Minimal SmokersActive, not recruitingNCT03777384
- TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the NeckCompletedNCT03729518Not applicable
- Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal CancerActive, not recruitingNCT03691441Phase 4
- Men and Women Offering Understanding of Throat HPVActive, not recruitingNCT03644563
- Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell CanerTerminatedNCT03618134Phase 1/2
- Interim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation TherapyWithdrawnNCT03611205Not applicable
- Evaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal CancersStatus unknownNCT03604588Not applicable
- NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 TherapyActive, not recruitingNCT03589339Phase 1
- CytID Analysis of Oral LesionsTerminatedNCT03555721
- Early Enteral Nutritional Supplementation on Patients With Oral and Oropharyngeal Cancer Undergoing Radio(Chemo)Therapy After SurgicalCompletedNCT03545490Phase 2
- Outcomes of Prophylactic Swallowing Therapy in Patients Undergoing Definitive Chemoradiation for Head and Neck CancerCompletedNCT03435471Not applicable
- PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved SwallowingWithdrawnNCT03423264Phase 2
- Functional Outcome After Treatment for Oropharyngeal Squamous Cell CarcinomaStatus unknownNCT03418909
- Functional Sparing of Salivary Glands Using MRI Sialography for Patients Undergoing Definitive Radiation Therapy for Head and Neck Cancers of the OropharynxCompletedNCT03418792Not applicable
- Chemoradiation vs Immunotherapy and Radiation for Head and Neck CancerActive, not recruitingNCT03383094Phase 2
- Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer PreventionCompletedNCT03346915Not applicable
- PET-MRI Assessment of Early Tumor Response to Predict Outcomes of HPV-Positive Oropharynx Cancer PatientsCompletedNCT03342378
- The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal TumorsCompletedNCT03302676Not applicable
- Clinical Evaluation of the OncAlert RAPID in Subjects Presenting for Evaluation and/or Initial Biopsy; Impact on Decision-MakingCompletedNCT03239834
- New Modalities for Detection of Oropharyngeal CancerCompletedNCT03226613Not applicable
- Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal CancerActive, not recruitingNCT03224000Phase 2
- Primary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal CancerActive, not recruitingNCT03210103Not applicable
- Feasibility of Radiofrequency Resection in Oropharyngeal Tumor SurgeryCompletedNCT03175770
- Adaptive Radiotherapy for Head and Neck CancerCompletedNCT03096808Phase 2
- Isocapnic Hyperventilation - an Alternative MethodCompletedNCT03074110Not applicable
- A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic SurgeryCompletedNCT03010813Not applicable
- Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal CarcinomaActive, not recruitingNCT02984410Not applicable
- CaptHPV : Validation of the Method "CaptHPV" for the Diagnosis of Human Papillomavirus Associated Infiltrating CarcinomasCompletedNCT02981862Not applicable
- uPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal CancerStatus unknownNCT02960724Phase 2
- 18F-FDG-PET Guided Dose-Painting With Intensity Modulated Radiotherapy in Oropharyngeal TumoursCompletedNCT02953197Phase 1
- Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx CancerActive, not recruitingNCT02945631Not applicable
- Impact of HPV Vaccine On The Prevalence Of HPV In NorwayCompletedNCT02934724
- Definitive Chemo-Radiotherapy for Regionally Advanced Head and Neck Cancer With or Without Up-front Neck DissectionCompletedNCT02918955Phase 3
- Obstructive Sleep Apnea Syndrome After Oropharyngeal Cancer TreatmentStatus unknownNCT02881723Not applicable
- Robotic Surgery in the Seated Position for Benign and Malignant Lesions of the Head and NeckCompletedNCT02792322Not applicable
- Dose Escalation Versus Standard in Laryngopharyngeal CancersCompletedNCT02757222Not applicable
- A Study of Mucosal Sparing Proton Beam Therapy (PBT) in Resected Oropharyngeal TumorsCompletedNCT02736786
- Image-Guided Stereotactic Radiosurgery (SRS) Boost for HPV-Oropharyngeal CancerCompletedNCT02703493Not applicable
- Cardiopulmonary Fitness in Long-Term Survivors of HPV-related Oropharynx CancersWithdrawnNCT02628912
- HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3CompletedNCT02558803Not applicable
- Swallowing, Speech and Quality of Life of Patients With Carcinoma of the OropharynxTerminatedNCT02552550
- Establishing Lymphedema and Fibrosis Measures in Oral Cancer PatientsCompletedNCT02412241Not applicable
- Improving Trans-oral Surgical Outcomes Through Intra-operative Image GuidanceCompletedNCT02405000Not applicable
- Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal CancerCompletedNCT02365844
- Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal CancerCompletedNCT02338102Not applicable
- Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell CarcinomaWithdrawnNCT02298595Phase 1/2
- A Post-Market Clinical Trial for Access and Visualization of the Oropharynx, Hypopharynx and Larynx During Transoral ProceduresCompletedNCT02262247
- Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer PatientsActive, not recruitingNCT02253238Not applicable
- Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerCompletedNCT02245100
- Robotic Surgery for Oropharyngeal Squamous Cell CarcinomaTerminatedNCT02225496Phase 2
- Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)Active, not recruitingNCT02215265Phase 3
- Exosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell CarcinomaCompletedNCT02147418
- Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx CancerCompletedNCT02048020Phase 2
- Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)TerminatedNCT02045186Not applicable
- Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT02035527Phase 1
- HPV Serum DNA Levels Predicting Outcome in p16+ Squamous Cell Head and Neck CancerCompletedNCT01984359Not applicable
- Radiation Therapy and Cisplatin With or Without Surgery in Treating Patients With Stage III-IV Oropharyngeal CancerWithdrawnNCT01953952Phase 2